Literature DB >> 25412957

Stoichiometric expression of MMP-2/TIMP-2 in benign and malignant tumours of the salivary gland.

Bamidele Kolude1, Akinyele Olumuyiwa Adisa, Ahmed Oluwatoyin Lawal, Bukola Folasade Adeyemi, Akindayo Olufunto Akinyamoju.   

Abstract

The aim of this study was to determine the expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitors of matrix metalloproteinase 2 (TIMP-2) and the MMP-2/TIMP-2 expression ratio in salivary gland tumours (SGTs). Forty-three FFPE SGTs were prepared for antibody processing to MMP-2 and TIMP-2. Two investigators utilizing Sinicrope's method scored the uptake of immuno-stains. Cytoplasmic staining was considered as positive. Data was analysed using SPSS version 20. The significance level was set at p < 0.05. In benign SGTs, the mean score for MMP-2 was not significantly lower than that of TIMP-2 (p = 0.37). However, the mean scores for MMP-2 stain intensity and proportion were significantly higher in malignant than benign SGTs (p = 0.01 and p = 0.02 respectively). There was no significant difference in the mean MMP-2/TIMP-2 expression ratio of the malignant SGTs according to histological grade and histogenesis (p = 0.4 and p = 0.19 respectively). The MMP-2/TIMP-2 expression ratio has a higher prognostic value than the separate expressions of MMP-2 and TIMP-2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25412957     DOI: 10.1007/s13277-014-2842-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

2.  Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma.

Authors:  T Yoshizaki; Y Maruyama; H Sato; M Furukawa
Journal:  Int J Cancer       Date:  2001-01-20       Impact factor: 7.396

3.  Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas.

Authors:  J G Batsakis; M A Luna
Journal:  Ann Otol Rhinol Laryngol       Date:  1990-10       Impact factor: 1.547

Review 4.  Matrix metalloproteinases in tumor invasion.

Authors:  N Johansson; M Ahonen; V M Kähäri
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

Review 5.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

6.  Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.

Authors:  Kaori Kayano; Taketoshi Shimada; Takashi Shinomiya; Shigeru Nakai; Yasuo Hisa; Takanori Aoki; Motoharu Seiki; Yasunori Okada
Journal:  J Pathol       Date:  2004-04       Impact factor: 7.996

7.  bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

Authors:  F A Sinicrope; S B Ruan; K R Cleary; L C Stephens; J J Lee; B Levin
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

8.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

9.  MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.

Authors:  D C Jinga; A Blidaru; Ileana Condrea; Carmen Ardeleanu; Cristina Dragomir; G Szegli; Maria Stefanescu; Cristiana Matache
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

10.  Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2).

Authors:  T Hayakawa; K Yamashita; E Ohuchi; A Shinagawa
Journal:  J Cell Sci       Date:  1994-09       Impact factor: 5.285

View more
  2 in total

1.  Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.

Authors:  Valéria Souza Freitas; Jean Nunes Dos Santos; Pedro Paulo de Andrade Santos; Cassiano Francisco Weege Nonaka; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-25       Impact factor: 2.503

2.  LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells.

Authors:  Mingguang Zhou; Zhihuai Dong; Sunhong Hu; Mang Xiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-21       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.